BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22138849)

  • 1. A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.
    Manji A; Lehrnbecher T; Dupuis LL; Beyene J; Sung L
    Support Care Cancer; 2012 Oct; 20(10):2295-304. PubMed ID: 22138849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia.
    Manji A; Lehrnbecher T; Dupuis LL; Beyene J; Sung L
    Pediatr Infect Dis J; 2012 Apr; 31(4):353-8. PubMed ID: 22173145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
    Paul M; Yahav D; Fraser A; Leibovici L
    J Antimicrob Chemother; 2006 Feb; 57(2):176-89. PubMed ID: 16344285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials.
    Sung L; Manji A; Beyene J; Dupuis LL; Alexander S; Phillips R; Lehrnbecher T
    Pediatr Infect Dis J; 2012 May; 31(5):431-5. PubMed ID: 22189521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
    Tang X; Chen L; Li Y; Jiang J; Li X; Liang X
    Medicine (Baltimore); 2020 Oct; 99(43):e22725. PubMed ID: 33120768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
    Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
    Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.
    Cometta A; Glauser MP
    J Chemother; 1996 Oct; 8(5):375-81. PubMed ID: 8957718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.
    Manji A; Beyene J; Dupuis LL; Phillips R; Lehrnbecher T; Sung L
    Support Care Cancer; 2012 Jun; 20(6):1135-45. PubMed ID: 22402749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
    Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
    J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors.
    Demir HA; Kutluk T; Ceyhan M; Yağcı-Küpeli B; Akyüz C; Cengiz B; Varan A; Kara A; Yalçın B; Seçmeer G; Büyükpamukçu M
    Pediatr Hematol Oncol; 2011 May; 28(4):299-310. PubMed ID: 21413829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
    Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
    Paul M; Soares-Weiser K; Leibovici L
    BMJ; 2003 May; 326(7399):1111. PubMed ID: 12763980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
    Matsuoka H; Tsukamoto A; Shirahashi A; Koga S; Suzushima H; Shibata K; Uozumi K; Yamashita K; Okamura S; Kawano F; Tamura K;
    Leuk Lymphoma; 2006 Aug; 47(8):1618-23. PubMed ID: 16966275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
    Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review.
    Torfoss D; Høiby EA; Holte H; Kvaløy S
    Acta Oncol; 2012 Apr; 51(4):433-40. PubMed ID: 22175253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the options for risk-based therapy in febrile neutropenia.
    Rolston KV
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):411-6. PubMed ID: 9635917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.